logo.jpg.png
TRxADE Group Reports First Quarter 2020 Financial Results
04 mai 2020 08h00 HE | Trxade Group, Inc.
Q1 2020 Revenues Increase 46% to $2.2 Million; Drives Net Income Increase of 44% to $0.2 Million TAMPA, FL, May 04, 2020 (GLOBE NEWSWIRE) -- Trxade Group, Inc., (NASDAQ: MEDS) (“Trxade” or the...
logo.jpg.png
TRxADE GROUP, INC. Sets Date for 2020 Annual Meeting of Stockholders
02 avr. 2020 16h15 HE | Trxade Group, Inc.
TAMPA, FL, April 02, 2020 (GLOBE NEWSWIRE) -- Trxade Group, Inc., (Nasdaq: MEDS)(“Trxade Group” or the “Company”), an integrated telehealth, drug procurement, delivery and healthcare platform that...
logo.jpg.png
Trxade Group, Inc. Files FDA Emergency Use Authorization for Rapid COVID-19 Testing Kit
01 avr. 2020 08h05 HE | Trxade Group, Inc.
TAMPA, FL, April 01, 2020 (GLOBE NEWSWIRE) -- Trxade Group, Inc. (NASDAQ: MEDS) an integrated drug procurement, delivery and healthcare platform, announces its wholly-owned subsidiary, Integra...
logo.jpg.png
TRxADE GROUP, INC. REPORTS 2019 RESULTS
30 mars 2020 08h05 HE | Trxade Group, Inc.
Delivered 2019 annual revenues of $7.43 Million (94.1% increase)Total Adjusted EBITDA of $852,647 (249% increase)Launched next generation of Telehealth Platform ( www.Bonumhealth.com ) Launched Drug...
logo.jpg.png
TRxADE GROUP, INC. Announces Exercise of Overallotment Option by Underwriters
24 févr. 2020 08h00 HE | Trxade Group, Inc.
TAMPA, FL, Feb. 24, 2020 (GLOBE NEWSWIRE) -- Trxade Group, Inc., (Nasdaq: MEDS)(“Trxade Group” or the “Company”), an integrated drug procurement, delivery and healthcare platform that enables price...
logo.jpg.png
TRxADE GROUP, INC. Announces Closing of Firm Commitment Common Stock Offering
18 févr. 2020 15h50 HE | Trxade Group, Inc.
TAMPA, FL, Feb. 18, 2020 (GLOBE NEWSWIRE) -- Trxade Group, Inc., (Nasdaq: MEDS)(“Trxade Group” or the “Company”), an integrated drug procurement, delivery and healthcare platform that enables price...
logo.jpg.png
TRxADE GROUP, INC. Announces Uplisting to Nasdaq Capital Market, Pricing of $5.2 Million Firm Commitment Public Offering of Common Stock and Effectiveness of Reverse Stock Split
13 févr. 2020 09h10 HE | Trxade Group, Inc.
Ticker Symbol Change to “MEDS” TAMPA, FL, Feb. 13, 2020 (GLOBE NEWSWIRE) -- Trxade Group, Inc., (Nasdaq: MEDS) (OTCQB: TRXD) (“Trxade Group” or the “Company”), an integrated drug procurement,...
logo.jpg.png
Trxade Group, Inc’s wholly-owned Bonum Health Subsidiary Teams Up with Benzer Pharmacy
21 nov. 2019 09h00 HE | Trxade Group, Inc.
Plans to launch “Bonum Health Hubs” in Benzer Pharmacies TAMPA, FL, Nov. 21, 2019 (GLOBE NEWSWIRE) -- Trxade Group, Inc. (OTCQB: TRXD) (“Trxade” or the “Company”), an integrated pharma supply...
logo.jpg.png
Bonum Health Introduces Next Generation Healthcare Resource
14 nov. 2019 09h00 HE | Trxade Group, Inc.
Coming Soon to a Pharmacy Near You: Introducing the Bonum Health Hub TAMPA, FL, Nov. 14, 2019 (GLOBE NEWSWIRE) -- Bonum Health, subsidiary to Trxade Group, Inc. (OTCQB: TRXD) (“Trxade” or the...
logo.jpg.png
Trxade Group Generates Record Revenues in Second Quarter 2019
29 juil. 2019 08h45 HE | Trxade Group, Inc.
Revenue Growth of 129% to $1.9 MillionOperating Income Growth of 322% to $132,7051st Half 2019 EPS of $0.01 TAMPA, FL, July 29, 2019 (GLOBE NEWSWIRE) -- Trxade Group, Inc. (OTCQB: TRXD), an...